As of 2025-10-30, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.42 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.62 CAD, the upside of Medicenna Therapeutics Corp is -187.66%.
Based on its market price of 1.62 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 187.66%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.42 - -1.42 | -1.42 | -187.66% |
| P/E | (0.51) - (0.77) | (0.64) | -139.4% |
| DDM - Stable | (2.26) - (9.92) | (6.09) | -476.0% |
| DDM - Multi | (1.79) - (6.42) | (2.84) | -275.3% |
| Market Cap (mil) | 74.69 |
| Beta | 2.12 |
| Outstanding shares (mil) | 46.11 |
| Enterprise Value (mil) | 54.40 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.68% |
| Cost of Debt | 5.00% |
| WACC | 9.67% |